11/2/2009

British drugmaker Shire PLC said clinical trial data showed its ADHD patch Daytrana reduced symptoms and was safe in children ages 13 to 17. Daytrana currently is approved for children ages 6 to 12.

Full Story:
Forbes

Related Summaries